Dr Liam Lawlor joined Murgitroyd in December 2022 as part of the acquisition of Turnbull Lynch Intellectual Property by Murgitroyd. Liam has worked on drafting and prosecution of patent applications covering a broad range of subject matters in the life sciences, biotechnology, medical devices and pharmaceutical sectors, particularly handling tissue engineering, peptide, dietary product, stem cell, virus, antibody and gene editing technologies (including CRISPR).
In addition to drafting and prosecution, Liam has experience in patent searching, patentability opinions, handling information disclosure requirements for clients and opposition work.
Liam is a fully qualified UK and European Patent Attorney with experience working with a very wide range of clients, including universities, SMEs and foreign attorneys. Liam enjoys working with clients to provide the best possible service, with a strong commercially-minded, client-focused, ethos.
Liam is based in our Leeds Office.
- Life Sciences
- Medical devices
- Tissue engineering
- Peptide technologies
- Stem cell technology
- Virus technology
- Antibody technologies
- Gene editing